Achilles therapeutics reports third quarter 2021 financial results and recent business highlights

- oral presentation at european society for gene and cell therapy (esgct) demonstrated ability to generate potent anti-cancer cell therapy candidates in multiple solid tumor types -

ACHL Ratings Summary

ACHL Quant Ranking